DOCSLIB.ORG

Use and Abuse of Amphetamine-Type Stimulants in the United States of America

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Use and Abuse of Amphetamine-Type Stimulants in the United States of America Temas de actualidad / Current topics In recent years the United States of America Use and abuse of has experienced economic growth, low unemploy- ment, low inflation, and technological advances. amphetamine-type However, coexisting with these favorable condi- stimulants in the United tions are underlying and underaddressed social in- equalities that may have an impact on patterns of States of America use and abuse of substances, including ampheta- mine-type stimulants (ATSs). For example, since 1975 most of the increase in national income has benefited people who are at the top 20% of the in- G. Cajetan Luna1 come range. There are disparities between those who do have and those who do not have the skills needed to thrive in a technologically dependent so- ciety, and the gap may be widening. New patterns of substance abuse being seen in the United States may in part be explained by the increasing compe- tition to survive financially and interpersonally, the need that those failing to adapt to rapid technolog- ical change have to escape psychologically and ex- istentially, and the desire of the socially alienated and disenfranchised to self-medicate with ATSs and at least temporarily avoid social and economical inequities. According to the 1998 National Household Survey on Drug Abuse, an estimated 13.6 million Americans were users of illicit drugs (1). This num- ber is less than the 13.9 million estimated for 1997, and by comparison less than the highest level, in 1979, when the estimate was 25 million. With re- spect to stimulants in particular, the overall level of usage has remained constant, but increases have been observed in specific high-risk populations, who need focused outreach and intervention ef- forts. This article will focus on ATSs in the United States, including relevant demographic and cul- tural dimensions of their use and abuse, and sug- gested directions for future ATS research and pro- gram development. ATS USE AND ABUSE IN THE UNITED STATES Key words: Drug abuse, amphetamines, United The history of ATS use and control States of America. For many decades in the United States pu- nitive actions have been taken against persons 1 AIDS Resources, Information, and Services of Santa Clara County, seeking substance-induced altered states of con- 380 N. First Street, Suite 200, San Jose, California 95112-4050, United States of America. Telephone: (408) 293-2747; fax: 408-293-0341; sciousness. These have ranged from the alcohol e-mail: [email protected] “prohibition” in the 1920s to the “drug bust” arrests 114 Temas de actualidad • Current topics of users in the psychedelic 1960s to the “war on States during the 1950s, large drug companies sold drugs” campaign of the 1980s. There are now more quantities of the drugs to bogus companies in care persons incarcerated in the United States for drug- of post office boxes. Known as “pep pills,” the related “crimes” than in any other country in the drugs were used for nonmedical purposes by many world. In 1997, 19% of prisoners in state facilities World War II veterans. In the 1960s, some doctors and 16% of those in Federal penitentiaries reported in San Francisco began prescribing amphetamine they had committed their current offense in order injections for treatment of heroin addiction. Other to obtain money for drugs (2). physicians, known as “script writers,” would, for The desire to expand reality, to lower inhi- the cost of an office visit, write prescriptions for bitions, or to soften the consequences of unpleas- amphetamines. ant life circumstances has remained consistent, but ATSs came under new, stricter controls with the popular or preferred substances employed for the passage of the Federal Drug Abuse Control Sub- those effects have varied with succeeding genera- stances Act of 1965. Subsequently, that legislation tions. Tobacco, alcohol, and marijuana are still the was consolidated with other laws into the Con- substances most widely abused by American chil- trolled Substances Act of 1970. That 1970 legislation dren and adolescents (3). regulates the manufacture and distribution of ATSs Various amphetamine compounds have been and other stimulants, as well as of narcotics, hallu- abused in the United States for over 90 years (4). cinogens, steroids, and chemicals used in the illicit Amphetamines comprise a large class of stimulants production of controlled substances. and include ones produced and used both legally Further limitations on ATSs came with the and illegally. When used appropriately, ampheta- Federal Domestic Chemical Diversion Act of 1993, mines can help reduce attention deficit hyperac- which controls the diversion of ephedrine and other tivity disorder, the most common psychiatric prob- legally obtainable chemicals for use in the illicit lem reported among children in the United States. production of controlled substances, including While widely prescribed for this disorder, amphet- methamphetamine and methcathinone. Ephedrine amines are also frequently diverted from prescrip- is present in many easily obtainable, legal products, tion to recreational use. Amphetamines can elevate including ones used to control coughs, asthma, and mood, promote feelings of euphoria, decrease inhi- allergies. Ephedrine occurs naturally in ma huang bitions, increase energy and alertness, reduce the (Ephedra equisetina), and it is a bronchodilator and a need for sleep, and suppress appetite (5). Users common ingredient in products for weight loss. have reported enhanced cognitive and physical abil- Ephedrine is structurally related to methampheta- it i es, as well as increased libido (6). mine, but ephedrine’s central nervous system ac- Among the legally produced pharmaceuticals tions are less potent. In 1995 the United States Food that are sometimes diverted to recreational use are and Drug Administration (FDA) mandated that methylphenidate (Ritalin) and phenmetrazine (Pre- producers of bronchodilator drugs remove from ludin). Illegally produced “street” ATS drugs in- them ephedrine and related ingredients, including clude amphetamine (in slang called “black beau- ephedrine hydrochloride, ephedrine sulfate, and ties,” “white bennies,” “speed”) and such related racephedrine hydrochloride. The FDA acted in re- compounds as dextroamphetamine (“dexies,” sponse to a request from United States Justice De- “beans”), methamphetamine (“crank,” “crystal,” partment’s Drug Enforcement Agency (DEA) to re- “meth”; also “speed”), methylenedioxymetham- strict over-the-counter (OTC) use of bronchodilator phetamine (MDMA, known as “ecstasy,” “XTC,” drugs because of their use as the primary precur- and “E”), and methcathinone (“cat,” “bathtub sor in the illicit synthesis of methamphetamine and speed,” “goob”). These illicit drugs can be con- methcathinone. sumed in different modes, including being taken A number of states in the United States have orally, injected, smoked, or snorted (inhaled into taken actions of their own to control products con- the nose). Injecting or smoking facilitates an imme- taining ephedrine. Of the 50 states in the country, diate, intense sensation, called a “rush.” at least 14 of them have switched products contain- Since the early 1900s, amphetamine users and ing ephedrine to prescription-only status. Several abusers have tended to be white males, persons liv- states have introduced legislation that would ing in the western United States, and individuals tighten controls on ephedrine, phenylpropanol- working in blue-collar, transportation, or service- amine, and other precursor chemicals used to il- related occupations. Other regular users and abusers legally produce ATSs. The attorney general of of amphetamine-type stimulants have included the state of Arizona plans legislation specifically athletes, college students, and those desiring quick limiting individual purchases of most ephedrine- weight loss. Although a prescription was required containing OTC cold and allergy medications (7). for the medical use of amphetamines in the United That legislation would limit purchases to 20 pack- Rev Panam Salud Publica/Pan Am J Public Health 9(2), 2001 115 ages in a 24-hour period. A major national chain of dioxymethamphetamine (MDMA), which is com- retail stores already restricts the number of pack- monly known as “ecstasy.” Ecstasy causes mesca- ages of these products that their customers can buy. line-like psychedelic effects. First used in the 1980s, If a customer exceeds the limit, the cash register au- ecstasy is found in many major cities and suburban tomatically shuts down. areas of the United States. Relatively inexpensive, the drug is popular among the young. Continuous “techno” music, rampant ecstasy use, and a “uto- ATS usage patterns and populations at risk pian” togetherness fuel urban dance scenes, includ- ing energetic all-night “raves” that feature euphoric ATS abuse occurs among a wide variety of marathon dancing and chemically induced “soul populations in the United States. Such users are expansion.” Clandestine by nature, raves are opti- predominately white middle-class teenagers and mally held in vast open-air environments, with the young adults. Amphetamines are also frequently location announced by promoters through flyers, used, in various forms, by male and female com- secret phone numbers, and Internet mailing lists. mercial sex workers (both street-based and through And while raves have declined more recently in organized call services), transgendered people, ha- some urban areas, they have grown in popularity in bitués of gay and
Load more

Recommended publications
  • Smoking Cessation Treatment at Substance Abuse Rehabilitation Programs
    SMOKING CEssATION TREATMENT AT SUBSTANCE ABUSE REHABILITATION PROGRAMS Malcolm S. Reid, PhD, New York University School of Medicine, Department of Psychiatry; Jeff Sel- zer, MD, North Shore Long Island Jewish Healthcare System; John Rotrosen, MD, New York University School of Medicine, Department of Psychiatry Cigarette smoking is common among persons with drug and alcohol n Nicotine is a highly use disorders, with prevalence rates of 80-90% among patients in sub- addictive substance stance use disorder treatment programs. Such concurrent smoking may that meets all of produce adverse behavioral and medical problems, and is associated the criteria for drug with greater levels of substance use disorder. dependence. CBehavioral studies indicate that the act of cigarette smoking serves as a cue for drug and alcohol craving, and the active ingredient of cigarettes, nicotine, serves as a primer for drug and alcohol abuse (Sees and Clarke, 1993; Reid et al., 1998). More critically, longitudinal studies have found tobacco use to be the number one cause of preventable death in the United States, and also the single highest contributor to mortality in patients treated for alcoholism (Hurt et al., 1996). Nicotine is a highly addictive substance that meets all of the criteria for drug dependence, and cigarette smoking is an especially effective method for the delivery of nicotine, producing peak brain levels within 15-20 seconds. This rapid drug delivery is one of a number of common properties that cigarette smok- ing shares with hazardous drug and alcohol use, such as the ability to activate the dopamine system in the reward circuitry of the brain.
    [Show full text]
  • EL PASO INTELLIGENCE CENTER DRUG TREND Synthetic Stimulants Marketed As Bath Salts
    LAW ENFORCEMENT SENSITIVE EPIC Tactical Intelligence Bulletins EL PASO INTELLIGENCE CENTER DRUG TREND TACTICAL INTELLIGENCE BULLETIN EB11-16 ● Synthetic Stimulants Marketed as Bath Salts ● March 8, 2011 This document is the property of the Drug Enforcement Administration (DEA) and is marked Law Enforcement Sensitive (LES). Further dissemination of this document is strictly forbidden except to other law enforcement agencies for criminal law enforcement purposes. The following information must be handled and protected accordingly. Summary Across the United States, synthetic stimulants that are sold as “bath salts”¹ have become a serious drug abuse threat. These products are produced under a variety of faux brand names, and they are indirectly marketed as legal alternatives to cocaine, amphetamine, and Ecstasy (MDMA or 3,4-Methylenedioxymethamphetamine). Poison control centers nationwide have received hundreds of calls related to the side-effects of, and overdoses from, the use of these potent and unpredictable products. Numerous media reports have cited bath salt stimulant overdose incidents that have resulted in emergency room visits, hospitalizations, and severe psychotic episodes, some of which, have led to violent outbursts, self-inflicted wounds, and even suicides. A number of states have imposed emergency measures to ban bath salt stimulant products (or the chemicals in them) including Florida, Louisiana, North Dakota, and West Virginia; and similar measures are pending in Hawaii, Kentucky, Michigan, and Mississippi. A prominent U.S.
    [Show full text]
  • Drug Prohibition and the Weakness of Public Policy
    Georgetown University Law Center Scholarship @ GEORGETOWN LAW 1994 Bad Trip: Drug Prohibition and the Weakness of Public Policy Randy E. Barnett Georgetown University Law Center, [email protected] This paper can be downloaded free of charge from: https://scholarship.law.georgetown.edu/facpub/1252 103 Yale L.J. 2593-2630 (1994) (reviewing Steven B. Duke & Albert C. Gross, AMERICA'S LONGEST WAR: RETHINKING OUR TRAGIC CRUSADE AGAINST DRUGS (1993)) This open-access article is brought to you by the Georgetown Law Library. Posted with permission of the author. Follow this and additional works at: https://scholarship.law.georgetown.edu/facpub Part of the Criminal Law Commons, Legislation Commons, and the Public Policy Commons Book Review Bad Trip: Drug Prohibition and the Weakness of Public Policy America's Longest War: Rethinking Our Tragic Crusade Against Drugs. By Steven B. Duke & Albert C. Gross. New York: G.P. Putnam's Sons, 1993. Pp. xix, 348. $26.95. Randy E. Barnettt INTRODUCTION Popular support for drug prohibition-especially among those who have given the matter any thought-is like support for George Bush just after Operation Desert Storm: very broad and very thin. Perhaps some personal experiences of mine will illustrate why. Personal Anecdote Number One: In the early morning hours of February 24, 1979, Michael Salcedo, his brother Arthur, and their friend Frank Mussa decided to buy some marijuana. Because marijuana is illegal, they could not go to the same legitimate businesses that sell tobacco or alcohol. So the three young men set out for Latin Eagles territory on the north side of Chicago; specifically to King Kastle, a hamburger stand that gang members were known t Professor of Law, Boston University School of Law.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • Subchronic Continuous Phencyclidine Administration Potentiates Amphetamine-Induced Frontal Cortex Dopamine Release
    Neuropsychopharmacology (2003) 28, 34–44 & 2003 Nature Publishing Group All rights reserved 0893-133X/03 $25.00 www.neuropsychopharmacology.org Subchronic Continuous Phencyclidine Administration Potentiates Amphetamine-Induced Frontal Cortex Dopamine Release Andrea Balla1, Henry Sershen1,2, Michael Serra1, Rajeth Koneru1 and Daniel C Javitt*,1,2 1 2 Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University School of Medicine, New York, NY, USA Functional dopaminergic hyperactivity is a key feature of schizophrenia. Etiology of this dopaminergic hyperactivity, however, is unknown. We have recently demonstrated that subchronic phencyclidine (PCP) treatment in rodents induces striatal dopaminergic hyperactivity similar to that observed in schizophrenia. The present study investigates the ability of PCP to potentiate amphetamine-induced dopamine release in prefrontal cortex (PFC) and nucleus accumbens (NAc) shell. Prefrontal dopaminergic hyperactivity is postulated to underlie cognitive dysfunction in schizophrenia. In contrast, the degree of NAc involvement is unknown and recent studies have suggested that PCP-induced hyperactivity in rodents may correlate with PFC, rather than NAc, dopamine levels. Rats were treated with 5–20 mg/kg/day PCP for 3–14 days by osmotic minipump. PFC and NAc dopamine release to amphetamine challenge (1 mg/kg) was monitored by in vivo microdialysis and HPLC-EC. Doses of 10 mg/kg/day and above produced serum PCP concentrations (50–150 ng/ml) most associated with PCP psychosis in humans. PCP-treated rats showed significant, dose-dependent enhancement in amphetamine-induced dopamine release in PFC but not NAc, along with significantly enhanced locomotor activity. Enhanced response was observed following 3-day, as well as 14-day, treatment and resolved within 4 days of PCP treatment withdrawal.
    [Show full text]
  • Substance Abuse: the Pharmacy Educator’S Role in Prevention and Recovery
    Substance Abuse: The Pharmacy Educator’s Role in Prevention and Recovery Curricular Guidelines for Pharmacy: Substance Abuse and Addictive Disease i Curricular Guidelines for Pharmacy: Substance Abuse and Addictive Disease1,2 BACKGROUND OF THE CURRICULUM DEVELOPMENT PROJECT In 1988, the AACP Special Interest Group (SIG) on Pharmacy Student and Faculty Impairment (renamed Substance Abuse Education and Assistance) undertook the development of curricular guidelines for colleges/schools of pharmacy to facilitate the growth of educational opportunities for student pharmacists. These Curricular Guidelines for Pharmacy Education: Substance Abuse and Addictive Disease were published in 1991 (AJPE. 55:311-16. Winter 1991.) One of the charges of the Special Committee on Substance Abuse and Pharmacy Education was to review and revise the 1991 curricular guidelines. Overall, the didactic and experiential components in the suggested curriculum should prepare the student pharmacist to competently problem-solve issues concerning alcohol and other drug abuse and addictive diseases affecting patients, families, colleagues, themselves, and society. The guidelines provide ten educational goals, while describing four major content areas including: psychosocial aspects of alcohol and other drug use; pharmacology and toxicology of abused substances; identification, intervention, and treatment of people with addictive diseases; and legal/ethical issues. The required curriculum suggested by these guidelines addresses the 1 These guidelines were revised by the AACP Special Committee on Substance Abuse and Pharmacy Education. Members drafting the revised guidelines were Edward M. DeSimone (Creighton University), Julie C. Kissack (Harding University), David M. Scott (North Dakota State University), and Brandon J. Patterson (University of Iowa). Other Committee members were Paul W. Jungnickel, Chair (Auburn University), Lisa A.
    [Show full text]
  • Drug and Alcohol Abuse Prevention Handbook FOREWARD
    Drug and Alcohol Abuse Prevention Handbook FOREWARD Grayson College recognizes that the illicit use of drugs and/or the abuse of alcohol are a persistent health problem of major proportion affecting our society physically, mentally, and socially. Illicit drug use and /or alcohol abuse can adversely affect an individual’s personal life, safety, health, and mental and physical performance. It is the intent of GC to provide employees and students pertinent information related to illicit drug use and/or alcohol abuse in an effort to prevent such harm. GC is committed to promoting and maintaining a work and academic environment that is free from illegal alcohol and drug use and abuse, in accordance with all federal, state, and local laws. Students, employees, and visitors are prohibited from possessing, consuming, manufacturing, dispensing, or being under the influence of alcohol/illegal drugs or engaging in improper self- medication while on college property or college business. Any member of the college community who violates this policy is subject to both prosecution and punishment under federal, state, and local laws to disciplinary proceedings by the college. This alcohol/drug policy is not designed to punish people for seeking rehabilitation. All information about those individuals who voluntarily avail themselves of drug or alcohol counseling or rehabilitation will not be used as a basis for disciplinary action or be used against an individual in any way. College employees and students who violate the alcohol/drug policy shall be informed about and referred to services to assist them in determining whether they are abusing drugs and alcohol or are chemically dependent.
    [Show full text]
  • Ecstasy Or Molly (MDMA) (Canadian Drug Summary)
    www.ccsa.ca • www.ccdus.ca November 2017 Canadian Drug Summary Ecstasy or Molly (MDMA) Key Points Ecstasy and molly are street names for pills or tablets that are assumed to contain the active ingredient 3,4-methylenedioxy-N-methamphetamine (MDMA). Although most people consuming ecstasy or molly expect the main psychoactive ingredient to be MDMA, pills, capsules and powder sold as ecstasy or molly frequently contain other ingredients (such as synthetic cathinones or other adulterants) in addition to MDMA and sometimes contain no MDMA at all. The prevalence of Canadians aged 15 and older reporting past-year ecstasy use is less than 1%. 1 in 25 Canadian youth in grades 10–12 have reported using ecstasy in the past 12 months. Introduction Ecstasy and molly are street names for pills, capsules or powder assumed to contain MDMA (3,4- methylenedioxy-N-methamphetamine), a synthetically derived chemical that is used recreationally as a party drug. Pills are typically coloured and stamped with a logo. These drugs are made in illegal laboratories, often with a number of different chemicals, so they might not contain MDMA or contain MDMA in amounts that vary significantly from batch to batch. Other active ingredients found in tablets sold as ecstasy or molly in Canada in 2016–2017 include synthetic cathinones or “bath salts” such as ethylone, methylenedioxyamphetamine (MDA) and its precursor methylenedioxyphenylpropionamide (MMDPPA). Other adulterants reported were caffeine, procaine, methylsulfonylmethane (MSA)and methamphetamine.1 In 2011–2012, paramethoxymethamphetamine (PMMA) was present in pills sold as ecstasy in Canada. This adulteration resulted in the deaths of 27 individuals in Alberta and British Columbia over an 11-month period.2 Effects of Ecstasy Use The effects of ecstasy are directly linked to the active ingredients in the pill.
    [Show full text]
  • Hallucinogens and Dissociative Drugs
    Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs — which have street names like acid, angel dust, and vitamin K — distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD, psilocybin, peyote, DMT, and ayahuasca cause HALLUCINOGENS AND emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, DISSOCIATIVE DRUGS ketamine, dextromethorphan, and Salvia divinorum may make a user feel out of Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, control and disconnected from their body PCP, Ketamine, Dextromethorphan, and Salvia and environment. In addition to their short-term effects What Are on perception and mood, hallucinogenic Hallucinogens and drugs are associated with psychotic- like episodes that can occur long after Dissociative Drugs? a person has taken the drug, and dissociative drugs can cause respiratory allucinogens are a class of drugs that cause hallucinations—profound distortions depression, heart rate abnormalities, and in a person’s perceptions of reality. Hallucinogens can be found in some plants and a withdrawal syndrome. The good news is mushrooms (or their extracts) or can be man-made, and they are commonly divided that use of hallucinogenic and dissociative Hinto two broad categories: classic hallucinogens (such as LSD) and dissociative drugs (such drugs among U.S. high school students, as PCP). When under the influence of either type of drug, people often report rapid, intense in general, has remained relatively low in emotional swings and seeing images, hearing sounds, and feeling sensations that seem real recent years.
    [Show full text]
  • Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs
    Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs Douglas M. Ziedonis, M.D., M.P.H.; Joseph Guydish, Ph.D., M.P.H.; Jill Williams, M.D.; Marc Steinberg, Ph.D.; and Jonathan Foulds, Ph.D. Despite the high prevalence of tobacco use among people with substance use disorders, tobacco dependence is often overlooked in addiction treatment programs. Several studies and a meta-analytic review have concluded that patients who receive tobacco dependence treatment during addiction treatment have better overall substance abuse treatment outcomes compared with those who do not. Barriers that contribute to the lack of attention given to this important problem include staff attitudes about and use of tobacco, lack of adequate staff training to address tobacco use, unfounded fears among treatment staff and administration regarding tobacco policies, and limited tobacco dependence treatment resources. Specific clinical-, program-, and system-level changes are recommended to fully address the problem of tobacco use among alcohol and other drug abuse patients. KEY WORDS: Alcohol and tobacco; alcohol, tobacco, and other drug (ATOD) use, abuse, dependence; addiction care; tobacco dependence; smoking; secondhand smoke; nicotine; nicotine replacement; tobacco dependence screening; tobacco dependence treatment; treatment facility-based prevention; co-treatment; treatment issues; treatment barriers; treatment provider characteristics; treatment staff; staff training; AODD counselor; client counselor interaction; smoking cessation; Tobacco Dependence Program at the University of Medicine and Dentistry of New Jersey obacco dependence is one of to the other. The common genetic vul­ stance use was considered a potential the most common substance use nerability may be located on chromo­ trigger for the primary addiction.
    [Show full text]
  • Drugs That Can Cause Delirium (Anticholinergic / Toxic Metabolites)
    Drugs that can Cause Delirium (anticholinergic / toxic metabolites) Deliriants (drugs causing delirium) Prescription drugs . Central acting agents – Sedative hypnotics (e.g., benzodiazepines) – Anticonvulsants (e.g., barbiturates) – Antiparkinsonian agents (e.g., benztropine, trihexyphenidyl) . Analgesics – Narcotics (NB. meperidine*) – Non-steroidal anti-inflammatory drugs* . Antihistamines (first generation, e.g., hydroxyzine) . Gastrointestinal agents – Antispasmodics – H2-blockers* . Antinauseants – Scopolamine – Dimenhydrinate . Antibiotics – Fluoroquinolones* . Psychotropic medications – Tricyclic antidepressants – Lithium* . Cardiac medications – Antiarrhythmics – Digitalis* – Antihypertensives (b-blockers, methyldopa) . Miscellaneous – Skeletal muscle relaxants – Steroids Over the counter medications and complementary/alternative medications . Antihistamines (NB. first generation) – diphenhydramine, chlorpheniramine). Antinauseants – dimenhydrinate, scopolamine . Liquid medications containing alcohol . Mandrake . Henbane . Jimson weed . Atropa belladonna extract * Requires adjustment in renal impairment. From: K Alagiakrishnan, C A Wiens. (2004). An approach to drug induced delirium in the elderly. Postgrad Med J, 80, 388–393. Delirium in the Older Person: A Medical Emergency. Island Health www.viha.ca/mhas/resources/delirium/ Drugs that can cause delirium. Reviewed: 8-2014 Some commonly used medications with moderate to high anticholinergic properties and alternative suggestions Type of medication Alternatives with less deliriogenic
    [Show full text]
  • Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
    Pharmacology and Toxicology of Amphetamine and Related Designer Drugs U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol Drug Abuse and Mental Health Administration Pharmacology and Toxicology of Amphetamine and Related Designer Drugs Editors: Khursheed Asghar, Ph.D. Division of Preclinical Research National Institute on Drug Abuse Errol De Souza, Ph.D. Addiction Research Center National Institute on Drug Abuse NIDA Research Monograph 94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Pharmacology and Toxicology of Amphetamine and Related Designer Drugs ACKNOWLEDGMENT This monograph is based upon papers and discussion from a technical review on pharmacology and toxicology of amphetamine and related designer drugs that took place on August 2 through 4, 1988, in Bethesda, MD. The review meeting was sponsored by the Biomedical Branch, Division of Preclinical Research, and the Addiction Research Center, National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other matieral in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors.
    [Show full text]